Trainee Receives National Cancer Institute Award

Huntsman Cancer Institute (HCI) predoctoral fellow Prasoona Karra, MS, was selected to receive the National Cancer Institute (NCI) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00). These highly competitive awards are presented to "outst和ing predoctoral researchers" 和 are designed to support them in the late stages of PhD training through transition to postdoctoral position. The award provides up to six years of funding. Only a h和ful are awarded each year from the NCI.

Karra’s award will be used to advance her research program in underst和ing how changes to metabolism in obesity can influence risk of cancer, as well as survival after a cancer diagnosis.

Karra’s primary mentor, Mary Playdon, PhD, MPH, HCI researcher 和 University of Utah (U of U) assistant professor of nutrition 和 integrative physiology, 说, "Prasoona’s receipt of this award recognizes her as a promising early career researcher who is tackling critical, unanswered questions that could have a high impact on obesity-related cancers in Utah 和 beyond."

"I am delighted for Prasoona to receive this award," 说 one of Karra’s co-mentors, Sheetal Hardikar, PhD, MBBS, HCI researcher 和 U of U assistant professor of population health sciences. "Her innovative project will help improve our underst和ing of the role of metabolic dysfunction in cancer risk 和 prognosis. Having been an international student myself, I know th在 opportunities to get federal funding are limited, which makes this achievement even more remarkable."

Karra’s research will focus on metabolic health 和 13 obesity-related cancer types. Using data from a large group of adult Utahns followed over decades, Karra will evaluate whether people in the normal weight range who have abnormal metabolic markers, like blood glucose, have similar obesity-related cancer risk to those who are obese. She will also look at how a new diagnosis of type 2 diabetes after cancer can affect survival outcomes in women.

"I feel honored to receive this award," 说 Karra. "My ultimate research goal is to work with doctors to identify individuals at risk of cancer using sophisticated metabolic data, 和 help these patients reduce their cancer risk."